Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$17.08 1.28 | 8.1%
06/26/17 - 04:00 PM ET
Company Cash Flow
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Cash Flow From Operating Activities
Net Income (Loss) -2.41B -288.00M 880.00M -863.60M
Operating Gains/Losses 10.00M 25.00M -124.00M 75.20M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -34.00M -626.00M -572.00M -300.60M
(Increase) Decrease in Inventories -164.00M -276.00M -193.00M -122.70M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -144.00M 325.00M 318.00M -76.50M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 1.85B 736.00M 425.00M 619.30M
Net Cash From Continuing Operations 2.09B 2.26B 2.31B 1.04B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 2.09B 2.26B 2.31B 1.04B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 17.00M 67.00M 53.00M 35.20M
Purchases of Property, Plant & Equipment -291.00M -303.00M -471.00M -184.90M
Acquisitions 180.00M -15.45B 390.00M -5.21B
Purchases of Short-Term Investments -1.00M -49.00M -72.00M -18.20M
Other Cash from Investing Activities -30.00M -31.00M 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -125.00M -15.58B -100.00M -5.38B
Issuance of Debt 1.22B 17.82B 1.65B 8.41B
Cash Used for Financing Activities
Issuance of Capital Stock 33.00M 30.00M 17.00M 10.00M
Repayment of Long-Term Debt -2.44B -5.19B -3.92B -6.40B
Repurchase of Capital Stock 0.00 -72.00M 0.00 -55.60M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -780.00M 1.03B -210.00M 2.06B
Net Cash From Financing Activities -1.96B 13.62B -2.46B 4.03B
Effect of Exchange Rate Changes -54.00M -30.00M -29.00M -5.20M
Net Change in Cash & Cash Equivalents -55.00M 274.00M -277.00M -315.80M

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases

Partner Headlines for VRX

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter